Pricing Log in Create free account

Cassava Sciences, Inc. (FLNA) vs NextCure, Inc. (NXTC)

Cassava Sciences, Inc. and NextCure, Inc. are both Biotechnology companies. Cassava Sciences, Inc. and NextCure, Inc. are of similar size ($23.4M and $21.8M). Across the 8 metrics below, Cassava Sciences, Inc. leads on 4 and NextCure, Inc. on 4.

Valuation

Metric FLNA NXTC Biotechnology median
P/E n/m n/m 10.60
P/S n/m 1.03 9.40
P/B 0.34 2.32 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 1.35 n/m 0.66
EV/Sales n/m 0.39 9.02
Earnings yield (193.33%) (193.55%) (32.88%)
Free cash flow yield (135.06%) (133.11%) (23.13%)

Profitability

Metric FLNA NXTC Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (55.78%) (195.22%) (51.96%)
Return on assets (35.34%) (121.60%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FLNA NXTC Biotechnology median
Revenue growth (TTM) 277.58% — 6.76%
EPS growth (last fiscal year) (28.77%) 17.75% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FLNA NXTC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 3.47 4.97
Net debt to EBITDA 1.01 0.75 1.01

Dividend

Metric FLNA NXTC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FLNA NXTC Biotechnology median
Market cap 21.79m 23.44m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack